• SuperCom is an electronic monitoring (“EM”) innovator helping to establish public safety and well-being through the use of advanced technology and monitoring services for government clients that make increasing use of supervised-release programs
• During a recent investor presentation at the annual LD Micro Invitational, SuperCom’s president and CEO, Ordan Trabelsi, outlined the company’s services and critical benefits to clientele, along with the company’s corresponding success with over 50 governments and 100,000 individuals served
• SuperCom anticipates that its $32 million contract in Romania, largely focused on monitoring domestic violence offenders, will help boost its credibility with other European governments running monitoring programs of a similar nature

Governments worldwide are turning to electronic monitoring (“EM”) solutions as a means of sustaining public safety and reducing repeat criminal behavior while also reducing the costs associated with imprisoning individuals — a trend outlined by EM innovator SuperCom (NASDAQ: SPCB) at a recent investor LD Micro presentation. SuperCom President and CEO Ordan Trabelsi explained the competitive edge of the company’s GPS-enabled PureSecurity platform, among a narrow field of rivals, during his appearance at LD Micro’s 17th annual invitational on Oct. 30 (https://ibn.fm/XPMXE). Trabelsi participated in one-on-one interviews with potential investors over the course of the event’s three days in Southern California.

SuperCom was founded in 1988 and has a track record of serving over 50 governments and 100,000 individuals. Its CAGR is above 60%, with 73% recurring revenue and a five-year EBITDA of $4.8 million as of last year.

“Our run-rate this year is even higher. We had a run-rate of at least $7.2 million EBITDA,” Trabelsi said.

SuperCom’s end-to-end solution provides a developed GPS technology for reliable offender tracking and 24/7 monitoring services to give criminal justice clients the confidence they need to operate supervised-release programs that allow select individuals to remain free from incarceration, potentially productive at their jobs and homes, at a fraction of incarceration costs.

“Over half a percent of the U.S. is in prison. That’s a very high rate; certainly not effective, not cost-effective, and not effective in terms of increasing public safety. … If you put someone on house arrest, you’re saving 90% of the costs, direct costs,” Trabelsi said. “And that’s just a sign that we need to improve things in the U.S., and also in other areas of the world, there’s room for improvement.”

SuperCom’s strategy is particularly focused on domestic violence cases in which any specifically identified victims or potential victims, as well as the authorities, can be notified by smartphone of the offender’s proximity before any physical danger arises.

“(It’s) one of the things that we in SuperCom are leaders in the world. We probably have more units in domestic violence than any other player out there,” Trabelsi said at the LD Micro event.

The technology is an improvement over bulky ankle monitors, offering instead a sleek, waterproof device that can be worn unobtrusively without drawing attention from other people. It has a battery life of up to one year, eliminating the need for continuous daily recharging with an electrical source.

SuperCom currently provides services in California’s large EM market and many other parts of Europe and the United States.

“We won a $32 million project in Romania,” Trabelsi said. “Not only is that a substantial project because Romania’s never done this before — and we’re talking about 15,000 offenders that we would be monitoring at any given point over the course of six years — but it also gives us a strong reference for any other projects around the world of similar size.”

The company’s services also include inmate monitoring in prisons, rehabilitation services and substance abuse monitoring — continuously evaluating a monitored subject’s alcohol intake through sweat-sensitive sensors, for example — and Trabelsi noted the company’s technology could work well for other services as well, although the company’s small size has led its officers to limit their focus to the most profitable opportunities at the moment.

“Our solutions create positive social impact and improve public safety worldwide,” Trabelsi said. “We see this over and over in various regions. We’re helping with saving the lives of potential victims. We’re aiding in eradicating domestic violence. We’re increasing public safety and well-being.”

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

• The company has an extensive IP portfolio, valid through 2040, and a drug pipeline in different preclinical and clinical stages, targeting cancer drug resistance and immune suppression.
• Kairos Pharma’s lead candidate ENV-105 is an antibody targeting CD105, a protein identified as a key driver of resistance to various cancer treatments.
• ENV-105 is in a Phase 2 trial for castrate-resistant prostate cancer (NCT05534646, in combination with Apalutamide) and a Phase 1 trial for EGFR-driven non-small cell lung cancer (NCT05401110, in combination with Osimertinib).
• The company is working with PreCheck Health Services to develop companion biomarkers for ENV-105, with the aim of identifying patients who will benefit most from being administered the drug candidate.
• Kairos is uniquely positioned to capitalize on the immunotherapy market, expected to reach $148 billion by 2030, as well as on the $11.3 billion prostate cancer market and the $14 billion EGFR-driven lung cancer market.

Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company, is dedicated to advancing innovative oncology therapies to overcome critical challenges in cancer drug resistance and immune suppression, two significant challenges to effective cancer treatment. With an extensive intellectual property portfolio valid until 2035 to 2040, the company is developing a notable pipeline of drugs tackling cancer drug resistance with a focus on overcoming impacting widespread cancers, including prostate and lung cancer, as well as reversing immune suppression.

Kairos Pharma’s pipeline includes multiple candidates in different clinical and preclinical stages:

• ENV-105: An antibody that targets CD105 — a protein identified as a key driver of resistance to various cancer treatments, this lead candidate is currently in a Phase 2 trial for castrate-resistant prostate cancer (NCT05534646 in combination with Apalutamide to overcome anti-androgen resistance) and a Phase 1 trial for EGFR-driven non-small cell lung cancer (NCT05401110 in combination with Osimertinib to address resistance).
• KROS-201: In the preclinical stage with preparation for a Phase 1 trial, this drug candidate targets glioblastoma and works by activating external T cells to target and destroy tumor cells. This candidate has received Investigational New Drug (“IND”) clearance from the Food and Drug Administration.
• KROS-101: In the preclinical stage, this drug candidate is designed to complement existing immunotherapies, showing promise in enhancing the immune system’s response by increasing the number and efficiency of T cells.
• KROS-102: In the preclinical stage, this drug candidate targets autoimmune diseases and works by decreasing T cell activity.
• KROS-301 and KROS-401: In the preclinical stage, both of these candidates focus on inhibiting cancer cell growth and tackling immune suppression in cancers such as triple-negative breast cancer.
• ENV-205: In the preclinical stage, this antibody targets Mitochondrial DNA with the goal of reversing resistance to chemotherapy in prostate cancer and others.

To achieve more accurate patient screening and monitoring for the ENV-105 Phase 1 and Phase 2 clinical trials, the company recently sealed a strategic agreement with PreCheck Health Services Inc., a CLIA-certified and CAP-accredited clinical laboratory specializing in genetic sequencing (https://ibn.fm/66UsY).

Under the terms of the partnership, PreCheck Health will focus on developing companion biomarkers for ENV-105, with the aim of advancing cancer treatment by identifying patients who will benefit most from being administered Kairos’s drug candidate. The two companies will utilize advanced molecular diagnostics to corroborate and further develop biomarkers previously identified in a Phase 2 clinical trial, with the goal of predicting patient responses to ENV-105 prior to treatment, in order to offer a more personalized approach to cancer care. The collaboration will rely on PreCheck’s proprietary SolidTumorCheck+ platform, which allows for gene expression profiling of tumor biopsies.

“This collaboration is an exciting step forward for Kairos Pharma. By working with PreCheck Health Services, we are advancing our mission to provide personalized cancer treatment solutions,” said Dr. John Yu, Kairos Pharma’s CEO. “The biomarkers we develop will enable us to tailor therapies to individual patients, improving their chances of a successful response to ENV105.”

The company also attended two major industry events in October, to discuss its drug development efforts and extensive pipeline. First, Dr. Yu participated in a fireside chat at the 2024 Maxim Healthcare Virtual Summit where he spoke with Jason McCarthy, Ph.D., Senior Managing Director, Head of Biotechnology Research at Maxim Group (https://ibn.fm/UxaE7). The summit was held virtually on Oct. 15 – 17. The Kairos Pharma CEO also presented a corporate overview at the LD Micro Main Event XVII, held on Oct. 28 – 30 in Los Angeles (https://ibn.fm/pnQmM).

With its innovative technologies to reverse key mechanisms of drug resistance and immune suppression of cancer and addressing underserved areas in cancer treatment, Kairos Pharma is strongly positioned to capitalize on the cancer therapy and immunotherapy markets by meeting substantial unmet needs. With ENV-105 in particular, the company has significant potential to capture a portion of the prostate cancer market, estimated at $11.3 billion, and the EGFR-driven lung cancer market, valued at $14 billion. The immunotherapy market, estimated to reach up to $148 billion by 2030, represents another major growth area for Kairos Pharma.

For more information, visit the company’s website at www.KairosPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to KAPA are available in the company’s newsroom at https://ibn.fm/KAPA

Dynamic Global Events recently concluded the 5th Next-Gen MSL Excellence conference, a premier event that brought together MSLs, field medical professionals and industry thought leaders to explore the best ways to grow “soft skills” and maintain productive KOL relationships. This engaging event highlighted innovative strategies, skills development and cutting-edge technologies that are shaping the future of MSLs and their crucial role in bridging scientific knowledge with clinical practice.

Key Takeaways from the Conference

The conference featured an impressive lineup of speakers, offering invaluable insights on how MSLs can excel in their roles and adapt to industry trends. Leaders from top pharmaceutical, biotech and medical device companies presented on a variety of topics aimed at enhancing the effectiveness of MSLs in their interactions with healthcare providers and other stakeholders.

Notable sessions included:

• Leveraging Digital Tools and Data for MSL Success: Experts discussed the importance of digital transformation, data analytics and artificial intelligence in improving engagement and insights, equipping MSLs with tools to better support decision-making and clinical outcomes.
• Advanced Communication and Relationship-Building Skills: Sessions focused on developing critical soft skills, including storytelling, empathy and adaptability, which are essential for building trusted relationships and conveying complex scientific information effectively.
• Insights from the Field: Industry leaders shared best practices and real-world experiences, providing attendees with actionable strategies to overcome common challenges, enhance their scientific knowledge, and demonstrate their value to key stakeholders.

Networking and Collaboration

In addition to insightful sessions, the conference included interactive networking opportunities where attendees could refine their skills in areas like virtual KOL engagement and management. The event fostered a collaborative atmosphere, offering ample networking opportunities to connect with peers, exchange ideas and discuss potential partnerships.

Building a Vision for the Future 

The Next-Gen MSL Excellence conference showcased how MSLs can continue to drive scientific and clinical dialogue forward, even amid rapid industry changes. Dynamic Global Events extends its gratitude to the speakers, attendees and sponsors who contributed to the success of this event. We’re excited to continue supporting MSLs in their pursuit of excellence and look forward to welcoming everyone back for future sessions on advancing the MSL profession.

Join the 6th KOL & MSL Expertise Summit on February 26-27, 2025.

To register, contact Marcie at mcruz@dgeconfs.com or 561-922-7817

To explore sponsorship opportunities, contact Amy at achapman@dgeconfs.com or 561-571-7687

• The successful calibration and benchmarking of the 4,400+ qubits Advantage2 processor is a significant milestone in D-Wave’s ongoing development of its sixth-generation annealing quantum computing system.
• Advantage2 has significantly more computational power than the current Advantage(TM) system, able to solve certain customer problems 25,000 times faster.
• Advantage2 offers improvements in areas such as faster time-to-solution, higher quality solutions, and ability to solve larger problems.

D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, has achieved a significant milestone in the ongoing development of its sixth-generation annealing quantum computing system by completing the calibration and benchmarking of a 4,400+ qubit Advantage2 processor (https://ibn.fm/SEoTd).

The Advantage2 processor has shown substantial performance gains, with more computational power than the current 5,000 qubit Advantage system, as demonstrated by recent performance benchmarks. Advantage2 has been able to solve a wide range of complex computational problems in areas such as optimization, artificial intelligence (“AI”) and materials science, in some cases 25,000 times faster than the current Advantage system.

To emphasize its capabilities across a wide range of quantum applications, the processor can also provide five times better solutions on problems that require advanced precision and was able to surpass the current Advantage system in 99% of tests on satisfiability problems.

The 4,400+ qubits Advantage2 processor can deliver significant improvements in the following areas:

• Qubit coherence time: doubled in comparison with the Advantage processor, which drives faster time to solution,
• Energy scale: increased by 40% to deliver higher-quality solutions,
• Qubit connectivity: increased from 15 to 20-way connectivity to enable solutions to larger problems.

“Our strategic decision to focus development efforts on enhancing the connectivity and coherence of our next annealing quantum computing system has proven successful,” said Dr. Trevor Lanting, chief development officer at D-Wave. “We’re thrilled with the performance of our recently calibrated processor, and we believe this technology will deliver amazing results for our customers, solving bigger and more complex problems.”

For more information, visit the company’s website at www.dwavequantum.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward Looking Statements

Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including the risks set forth under the heading “Risk Factors” discussed under the caption “Item 1A. Risk Factors” in Part I of our most recent Annual Report on Form 10-K or any updates discussed under the caption “Item 1A. Risk Factors” in Part II of our Quarterly Reports on Form 10-Q and in our other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law.

Several companies are touting novel artificial intelligence technologies that promise to revolutionize the job-search process. This development has emerged at a time when the rate at which people are looking for new jobs has reached very high levels. For example, data reveals that at least 28% of U.S. residents were recently job-hunting.

Jeff, a well-followed TikTok user, emphasized that as hiring managers incorporated more AI functions in the hiring process, applicants also need to go the extra mile in order to stand a chance of being hired. In his videos, Jeff walks viewers through the AI-backed processes. He adds that he was able to get a job after using AI to formulate his applications, practice how to respond to interview questions and make meaningful connections with potential employers.

Chantal Cowie, another ardent believer in the utility of AI tools in the job-search process, recently shared how helpful AI can be during a job hunt. She reveals that AI saved her precious time because she had a hectic 60-hour week schedule. By automating aspects of the job search with AI, she was able to save plenty of time. Cowie says AI helped her to apply to a lot more jobs and advance further than had been previously possible in the rounds of interviews for each role. She secured a six-figure position that is fully remote as a result of leveraging AI tools.

As AI becomes increasingly popular in the job search process, many platforms have emerged to serve individuals who need help in landing a suitable and rewarding job. AI Hawk, Simplify and LazyApply are examples of platforms catering to this need. AI Hawk has a bold claim indicating that those who use their services have an 80% higher likelihood of landing a role in comparison to those who don’t use the service.

As these tools proliferate, some critics say the risk of errors and hallucination is high and users could be disadvantaged by the use of AI in the job search process. Others say automation erodes authenticity and could even disadvantage employers since they may select an individual whose application documents were embellished by AI.

Those concerns notwithstanding, the use of AI in everyday life activities is growing. The companies behind those AI tools could be basking in the limelight of their innovations, but behind this revolution lies several unsung heroes; including metals like gold and copper making it possible for AI components like chips and data centers to be built. Companies such as McEwen Mining Inc. (NYSE: MUX) (TSX: MUX), leveraging their expertise to help address the surging demand for those minerals, are well-positioned to capitalize on the rise of AI.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at http://ibn.fm/MUX

• ABC News reported that the price of gold climbed to an all-time high in October as uncertainty prompted investors to seek safe havens.
• Renforth Resources geologists are currently working to advance the knowledge of the Parbec project through several initiatives.
• The company is applying for stripping permits and undergoing a comprehensive geochemical analysis program.

This year has seen gold consistently increase in price, with many seeing the precious metal as an essential piece of a solid portfolio. In October, gold reached its all-time high — $2,790.07 — and many forecasters expect the price to go even higher before the year is over. With that as a backdrop, Renforth Resources (CSE: RFR) (OTCQB: RFHRF), an active mineral-exploration company engaged in the exploration and development of multicommodity mineral properties in Canada, released a report regarding new field work at its Quebec-based Parbec gold deposit (https://ibn.fm/aTtfB).

“The price of gold climbed to an all-time high [in October] as uncertainty about conflict in the Middle East and the U.S. presidential election sent investors in search of a safe haven,” reported ABC News (https://ibn.fm/Zinmo). “The latest jump is hardly a blip. Gold has soared about 32% since the outset of 2024, outpacing the 23% growth in the S&P 500 and a 28% surge in the tech-heavy NASDAQ over that same period.

“The monthslong stretch of strong performance owes in large part to an expectation of lower interest rates at the Federal Reserve, which typically coincide with an increase in gold prices, some analysts told ABC News,” the article continued. “They also pointed to purchases of gold reserves among central banks, as well as persistent demand from investors aiming to diversify their portfolio and hedge against global unrest.”

In its update for shareholders, Renforth Resources noted that its geologists are currently working to advance the knowledge of the Parbec project through several initiatives, including stripping permits and a comprehensive geochemical analysis program.

Renforth is in the process of applying for two stripping permits at Parbec gold deposit, with the objective of enhancing surface exposure by removing overburden and exposing bedrock and improving structural understanding of the site. “This will aid in creating improved surface visibility of underlying geological structures,” the company noted. “This will allow for more detailed mapping of the area.

“The exposed bedrock will provide valuable insights into the geological relationship between the Pontiac sediments and the Cadillac Break at Parbec,” the report continued. “This information is crucial for refining and validating Renforth’s current geological model of the deposit. Renforth has chosen these stripping locations due to their proximity to near-surface drill intersections. By exposing these zones at surface, Renforth aims to identify surface expressions of these drill intersections to serve as future bulk sampling locations.”

The company noted that the permit program was designed to complement its consistent efforts to advance the Parbec project, potentially leading to a more comprehensive understanding of the deposit’s near-surface gold potential and guiding future exploration and development strategies.

The geochemical analysis program at Parbec gold deposit is designed to determine the silver content within the Parbec deposit. The program will include the selection of representative core samples from previously assayed core, which will be submitted for multielement analysis. “The Cadillac Break, running through the Parbec Property, is widely recognized as a major deep-seated gold-bearing structure,” the company observed. “However, it is important to highlight that silver is produced at the adjacent Canadian Malartic Mine as well as at the former Lapa mine nearby.”

In addition, Renforth plans to apply an innovative analytical approach to core samples from Parbec, mirroring a successful technique employed at its Victoria polymetallic project. “This method involves a comprehensive core analysis of both mineralized and unmineralized material, using advanced sensing technology and proprietary algorithms developed by TOMRA,” the report stated. “This process allows for the identification and presorting of ore and waste material, potentially streamlining a future processing stream at Parbec. . . . Field work noted above will be commencing immediately, permit applications will be submitted shortly. Results of this work, when available, will be released.”

Renforth Resources is an active mineral-exploration company engaged in the exploration and development of the company’s wholly owned multicommodity mineral properties in Canada. In addition to the Parbec project, the company holds the Nixon Bartleman gold property in Ontario.

For more information, visit RenforthResources.com.

NOTE TO INVESTORS: The latest news and updates relating to RFHRF are available in the company’s newsroom at https://ibn.fm/RFHRF

• “In 2024, over 611,000 deaths from cancer are projected for the U.S.,” the ACA reported. “That’s more than 1,600 deaths from cancer each day.”
• Calidi Biotherapeutics’ RTNova (“CLD-400”) is an innovative systemic antitumor enveloped virotherapy, designed to unlock new possibilities in cancer therapy.
• RTNova offers a systemic approach that enables providers to target and treat metastatic tumors that were previously untouchable.

The American Cancer Society (“ACA”) has projected that 2024 will be the first year ever to see two million people diagnosed with cancer, which remains the second leading cause of death in the United States, after heart disease (https://ibn.fm/ADo2Q). Companies such as Calidi Biotherapeutics (NYSE American: CLDI) are working hard to discover more effective treatments to curb the rising numbers. Calidi recently presented key data at two prominent scientific conferences regarding its new generation of targeted antitumor virotherapies and viral vectors (https://ibn.fm/9johm).

“Over the last 30 years, the risk of dying from cancer has steadily declined, sparing some four million lives in the United States,” the ACA reported. “This downward trend can partially be explained by big wins in smoking cessation, early cancer detection and treatment advancements. Cancer incidence, however, is on the rise for many common cancers. In the coming year, we’re expecting to hit a bleak milestone — the first time new cases of cancer in the U.S. are expected to cross the two-million mark. That’s almost 5,500 cancer diagnoses a day.”

The report noted that the upward trend is impacted by the aging and growth of the population and by a rise in diagnoses of six of the 10 most common cancers: breast, prostate, endometrial, pancreatic, kidney and melanoma. The other four top-10 cancers are lung, colon and rectum, bladder, and non-Hodgkin lymphoma.

“In 2024, over 611,000 deaths from cancer are projected for the U.S.,” the report stated. “That’s more than 1,600 deaths from cancer each day.”

Developing new and improved cancer therapies is essential to enhance patient outcomes, reduce side effects and address the complexities of different cancer types. Ground-breaking treatments can provide more effective personalized care, targeting tumors while sparing healthy cells. Advances in immunotherapy, targeted therapies and precision medicine hold the potential to transform cancer from a life-threatening disease to a manageable condition. Additionally, with cancer incidence rising globally, continued research and development are critical to meeting the growing demand for accessible, life-saving treatments and improving the quality of life for millions.

Calidi Biotherapeutics’ RTNova (“CLD-400”) is an innovative systemic antitumor enveloped virotherapy, designed to unlock new possibilities in cancer therapy. The platform addresses challenges presented by untargetable and untreatable metastatic diseases and offers a possible potential transformative solution with wide-ranging applications. The company shared key information about RTNova at two recent conferences: the International Oncolytic Virotherapy Conference (“IOVC”) in Rotterdam, Netherlands, which was held Oct. 27–30, 2024, and Immuno U.S. 2024 in San Diego, California, which was held Oct. 28–30. In addition, the company reported a poster featuring RTNova was presented at the annual meeting of the Society for Immunotherapy of Cancer (“SITC”), which was held in Houston Nov. 6–10.

RTNova is a systemic treatment designed for reduced elimination by the humoral immune system. It targets multiple tumor sites, killing tumor cells while altering the tumor immune microenvironment. This novel therapeutic approach not only facilitates easier administration but also broadens the potential patient population that can benefit from this treatment.

“RTNova represents a groundbreaking advancement in cancer therapy, offering a systemic approach that enables us to target and treat metastatic tumors that were previously untouchable,” said Antonio F. Santidrian, PhD., Calidi’s chief scientific officer. “RTNova’s ability to fundamentally change the tumor microenvironment while delivering therapeutic viruses to multiple tumor sites has the potential to unlock new possibilities for patients facing some of the most challenging cancers. Ultimately, we believe RTNova has the potential to transform how we address previously untreatable metastatic diseases.”

Calidi Biotherapeutics is a clinical-stage, immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer. Calidi’s novel stem-cell-based platforms are utilizing potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade gliomas and solid tumors. Calidi’s clinical-stage, off-the-shelf, universal cell-based delivery platforms are designed to protect, amplify and potentiate oncolytic viruses, leading to enhanced efficacy and improved patient safety. Calidi’s preclinical off-the-shelf enveloped virotherapies are designed to target disseminated solid tumors. This dual approach can potentially treat, or even prevent, metastatic disease.

For more information, visit www.CalidiBio.com.

NOTE TO INVESTORS: The latest news and updates relating to CLDI are available in the company’s newsroom at https://ibn.fm/CLDI

• Aston’s CEO reports that drilling confirms the company’s geological model.
• The 2024 deep-drilling program has delivered further evidence of a very extensive laterally oriented deeper copper horizon that covers an area of more than 10 square kilometres (km2) and remains open.
• All three deeper drill holes in the 2024 program — collared approximately 2 km apart from each other — have intersected copper sulfides and prospective stratigraphy within the interpreted deeper copper horizon.
• Additional results from the 2024 campaign to be reported in the coming weeks.

Amid strategic diamond-drilling activities, Aston Bay Holdings (TSX.V: BAY) (OTC: ATBDF), a publicly traded mineral exploration company exploring for high-grade critical and precious metal deposits, has released an update on its Storm Copper Project (https://ibn.fm/c8kDQ). The project is located on Somerset Island, Nunavut, with exploration being conducted by American West Metals Limited.

According to the update, drill holes for the 2024 deep-drilling campaign are designed to test key geological targets at Storm as well as the potential for new zones of copper mineralization at the Deep Copper Horizon location, which was discovered in 2023.

“It is encouraging to receive confirmation of our geological model with the drill bit,” said Aston Bay CEO Thomas Ullrich. “Drilled to test stratigraphy and structure in a little-explored area, ST24-02 encountered a significant amount of sediment-hosted-style copper mineralization. While the mineralization at this location is spread out over a wide interval, it nevertheless highlights the pervasive nature of the mineralizing process at Storm and points to the potential where the copper budget of these pervasive fluids can be concentrated in higher-grade zones as in the near-surface copper deposits currently being defined at Storm.”

In addition, Ullrich provided an update regarding a third drill hole in the campaign, which “remains only partially completed due to drilling difficulties at the end of the season,” he noted. “Drilling in the frozen Arctic ground requires salt to be added to the drilling fluid to prevent freezing. Before reaching the target, the drill intercepted a fractured zone, resulting in the loss of the drilling fluid. Unfortunately, it was too late in the season to resupply the salt and other drilling additives necessary to continue the hole this year.

“The targeted anomaly exhibits characteristics of both fault-hosted Chinook-style and stratiform-hosted Cyclone-style mineralization, making it a very compelling target,” Ullrich concluded. “I eagerly look forward to completing this drill hole early next year.”

The Storm property consists of 173 contiguous mining claims covering an area of approximately 219,257 hectares on Somerset Island, Nunavut, Canada. The Storm property comprises both the Storm Copper Project, a high-grade sediment-hosted copper discovery, and the Seal Zinc Deposit. The company noted that there are also numerous underexplored and undrilled targets within the 120-kilometer strike length of the mineralized trend, including the Tornado copper prospect.

Aston Bay and American West have formed a 20/80 unincorporated joint venture with respect to the Storm Project property, with Aston Bay maintaining a free carried interest until a decision to mine is made upon completion of a bankable feasibility study.

Aston Bay is focused on exploring for high-grade critical and precious metal deposits in both Canada and the United States. The company is aggressively advancing the high-grade Storm Copper Project in Nunavut, Canada, toward development with partner American West Metals. The company is free carried for all expenditures at the project until decision to mine. Aston Bay is looking to replicate the success of Storm with its Epworth Copper Project, also located in Nunavut, where surface samples have yielded up to 61% copper with 5600 g/t silver as well as cobalt, zinc and gold. The company is also exploring the high-grade (up to 62.51 g/t Au) Buckingham Gold Vein and critical metals prospects in central Virginia.

For more information, visit AstonBayHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to ATBHF are available in the company’s newsroom at https://ibn.fm/ATBHF

Have you just taken a swing on a tough shot, and have no one to share it? What would it be like to record it and receive near-instant feedback from golfers who know their way around the greens? With GolfLync, a leading social networking platform aimed at revolutionizing the golf experience, this dream can easily become reality due to the app’s unique live feed feature.

Often dubbed “Tinder for Golf,” the GolfLync app isn’t just about connecting golfers — it’s a thriving platform for players to share tips and feedback, and enhance their game alongside a passionate community. This can be achieved via GolfLync’s live feed, where users can post videos and photos from the course and get real-time insights. Whether it’s a tricky green or a shot down an awkward fairway, the live feed connects players who share practical tips, playing techniques, and course recommendations, fostering a unique, skill-focused network.

The platform’s setup encourages constructive advice, helping you to refine your form with insights from fellow enthusiasts. And it doesn’t stop here — users can share everything from short game drills to course reviews and strategy tips, creating a unique resource for continuous improvement.

Each post on the live feed brings valuable insights, with GolfLync players benefitting from shared knowledge and encouragement. Whether you’re just starting or a seasoned player, the tips and guidance available through the GolfLync network will provide something fresh to integrate into your game.

So, if you’re looking to enhance your skills and connect with players who share your passion, GolfLync is waiting. Download the app, dive into the feed, and start improving your game alongside like-minded enthusiasts and golfing pros!

You can download the GolfLync app using the following text-anchored links:

• Android: GolfLync – Apps on Google Play
• iPhone: GolfLync

For more information about GolfLync, visit GolfLync, download the app, and connect with community on Facebook, X and LinkedIn.

NOTE TO INVESTORS: The latest news and updates relating to SportLync are available in the company’s newsroom at https://ibn.fm/SPORT

For additional investor information, visit SportLync Investment.

• Brera Holdings, an Ireland-based, international holding company with a global portfolio of men’s and women’s sports clubs, has reiterated its commitment to elevating Mozambique’s football landscape
• Seeing as it is ranked 183/193 on the Human Development Index (“HDI”) by the United Nations Development Program (“UNDP”), Brera recognizes the huge untapped opportunities to explore new initiatives to develop talent
• Since it entered this market in March 2023, Brera Tchumene FC has earned promotion to Maçambola, the country’s top-tier national league, and has since expanded its operations significantly
• Brera’s management shared this and more at the Soccerex Miami 2024 event held on November 13-14 in Miami, Florida

Brera Holdings (NASDAQ: BREA), an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership approach, has reiterated its commitment to elevate Mozambique’s football (soccer) landscape. Brera recognizes the vast untapped opportunity from an empowerment perspective and an economic one.

“Our vision is to not only elevate Mozambique’s football landscape but also play a crucial role in Africa’s overall football ecosystem,” noted Vasco Imparato, the CEO of Brera Tchumene FC. “We are building an operation that will attract talent, nurture excellence, and open doors for Mozambican players on the global stage,” he added (https://ibn.fm/ZJuY1).

Brera officially entered the African market in March 2023 by establishing Brera Tchumene FC in Mozambique. The country’s selection was not out of chance. Instead, Brera saw a largely untapped opportunity that would help advance its vision to deliver social impact. The United Nations Development Program (“UNDP”) currently ranks the country as 183rd out of 193 nations on the Human Development Index (“HDI”), which further highlights the opportunities that exist for Brera to explore new initiatives to develop talent and connect players with more competitive leagues globally (https://ibn.fm/64dMx).

With a history of success from the likes of Reinildo Mandava, who has since been signed to Atlético Madrid, and Geny Catamo, who is now part of the Sporting CP team in Portugal, Brera has demonstrated that its approach works. As such, it looks to extend its impact to more communities, allowing its players to excel at the highest levels (https://ibn.fm/ZJuY1).

So far, Brera Tchumene FC has stood out from its peers. In its inaugural season in 2023, the club earned promotion to Maçambola, the country’s top-tier national league, a significant milestone for the club. So far this year, the club has expanded its operations by establishing professional managerial departments in finance, human resources, communications, and commercial management. The club also launched women’s U-19 teams alongside its men’s senior team, demonstrating its commitment to inclusivity and long-term growth.

“Our mission is to provide young Mozambican men and women with the best conditions to develop their skills and create pathways for their success in more competitive leagues worldwide,” noted Mr. Imparato (https://ibn.fm/ZJuY1).

Brera’s management reiterated this mission at the Soccerex Miami 2024 event held on November 13 and 14 in Miami, Florida. The event brought together over 2,000 delegates for two full days of networking with senior soccer executives, engaging activities with exhibitors, and over 24 hours of content. Notable personalities took the stage, providing insights into topics integral to the global game, including, but not limited to, technology, growth of the women’s game, infrastructure, operations, sponsorship, and athlete development (https://ibn.fm/XoBs6).

Going into the event, Brera’s management looked to exchange ideas with various clubs, leagues, investors, and federations, ultimately gaining much-needed access and connections with key stakeholders who would help advance its goals.

“Our attendance enabled to stay connected to the pulse of global football while providing valuable opportunities to engage with industry leaders and promote Brera Holdings and our clubs and players,” noted Pierre Galoppi, Brera’s CEO. “As we own several clubs in different countries, Soccerex Miami provided a lot of useful information on trends involving leagues, clubs and players,” he added (https://ibn.fm/jDmJ7).

Brera remains bullish about the African continent, and its investment in Mozambique is a testament to that. It is confident not only in its bet on the continent but also in its people. As such, its management is optimistic that its investments will pay off as time progresses, yielding growth in shareholder value and a society empowered through soccer.

For company information, visit the company’s website at www.breraholdings.com.

NOTE TO INVESTORS: The latest news and updates relating to BREA are available in the company’s newsroom at https://ibn.fm/BREA